Interleukin-10 inhibits polymethylmethacrylate particle induced interleukin-6 and tumor necrosis factor-α release by human monocyte/macrophages in vitro

Michael C.D. Trindade, Martin Lind, Yasuharu Nakashima, Doohoon Sun, Stuart B. Goodman, David J. Schurman, R. Lane Smith

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Periprosthetic membranes commonly observed at sites of total joint implant loosening exhibit abundant macrophages and particulate debris. Macrophages phagocytose orthopedic debris and release the pro-inflammatory mediators interleukin-1, interleukin-6, tumor necrosis factor-α, and prostaglandin E2. Populations of activated lymphocytes are often seen in periprosthetic membranes. These lymphocytes may modulate the monocyte/macrophage response to particulate debris and influence aseptic loosening. In addition, other immunologic agents, such as interleukin-10, are present in tissues harvested from the bone-implant interface of failed total joint arthroplasties. The present study examined the effects of interleukin-10 on polymethylmethacrylate (PMMA) particle challenged human monocyte/macrophages in vitro. Human monocyte/macrophages isolated from buffy coats of five healthy individuals were exposed to 1-10 μm PMMA particles. Interleukin-10 was added to the monocyte/macrophages with and without the addition of PMMA particles. Interleukin-10-induced alterations in monocyte/macrophage metabolism were determined measuring interleukin-6 and tumor necrosis factor-α release by the cells following exposure to PMMA particles. Exposure of the monocyte/macrophages to PMMA particles resulted in a dose-dependent release of interleukin-6 and tumor necrosis factor-α at 48 h. Interleukin-10 reduced the levels of interleukin-6 and tumor necrosis factor-α release by macrophages in response to PMMA particles in a dose-dependent manner. At 48 h, particle-induced interleukin-6 release was inhibited by 60 and 90% with 1.0 and 10.0 ng/ml treatments of interleukin-10, respectively. At 48 h, particle-induced tumor necrosis factor-α release was inhibited by 58 and 88% with 1.0 and 10.0 ng/ml treatments of interleukin-10, respectively. Interleukin-10 challenge alone did not significantly alter basal interleukin-6 or tumor necrosis factor-α release relative to control cultures. The data presented in this study demonstrate that the anti-inflammatory cytokine, interleukin-10, inhibits monocyte/macrophage release of the pro-inflammatory cytokines interleukin-6 and tumor necrosis factor-α in response to PMMA particle challenge in vitro.

Original languageEnglish
Pages (from-to)2067-2073
Number of pages7
JournalBiomaterials
Volume22
Issue number15
DOIs
Publication statusPublished - Aug 1 2001
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Bioengineering
  • Ceramics and Composites
  • Biophysics
  • Biomaterials
  • Mechanics of Materials

Fingerprint Dive into the research topics of 'Interleukin-10 inhibits polymethylmethacrylate particle induced interleukin-6 and tumor necrosis factor-α release by human monocyte/macrophages in vitro'. Together they form a unique fingerprint.

Cite this